Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:07:21 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



News for U:TCON from 2023-05-07 to 2024-05-06 - 19 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-08 09:10U:TCONNews ReleaseTRACON Pharmaceuticals Announces Reverse Stock Split
2024-04-03 08:00U:TCONNews ReleaseTRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned
2024-03-05 16:02U:TCONNews ReleaseTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
2024-02-28 16:02U:TCONNews ReleaseTRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024
2023-12-20 08:00U:TCONNews ReleaseTRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial
2023-11-20 08:00U:TCONNews ReleaseTRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment
2023-11-09 16:02U:TCONNews ReleaseTRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
2023-10-31 16:02U:TCONNews ReleaseTRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023
2023-09-18 08:00U:TCONNews ReleaseTRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
2023-09-05 16:02U:TCONNews ReleaseTRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences
2023-08-14 16:02U:TCONNews ReleaseTRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
2023-08-02 16:05U:TCONNews ReleaseTRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023
2023-07-11 08:00U:TCONNews ReleaseTRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma
2023-06-20 08:00U:TCONNews ReleaseTRACON Pharmaceuticals Announces Positive Results Based on Ongoing Double-Digit Objective Response Rate for Single Agent Envafolimab in the ENVASARC Phase 2 Pivotal Trial
2023-06-16 08:00U:TCONNews ReleaseTRACON Pharmaceuticals to Present at the Maxim Group Healthcare Virtual Conference
2023-06-15 08:00U:TCONNews ReleaseTRACON Pharmaceuticals Announces Enforcement Action to Collect Binding Arbitration Award from I-Mab Biopharma
2023-06-02 08:00U:TCONNews ReleaseTRACON Pharmaceuticals to Present at the Jefferies Healthcare Conference
2023-05-30 08:00U:TCONNews ReleaseTRACON Pharmaceuticals Announces Poster Presentations for Envafolimab and TRC102 at the 2023 ASCO Annual Meeting
2023-05-10 16:02U:TCONNews ReleaseTRACON Pharmaceuticals Reports First Quarter 2023 Financial Results and ‚  Provides Corporate Update